Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Enterprise Development Holdings Limited ( (HK:1808) ) is now available.
Enterprise Development Holdings Limited, through its subsidiary, has invested RMB120 million in the Hainan Yayi Partnership, which focuses on biomedicine-related investments. The partnership has acquired a 14.16% equity interest in a Shenzhen-listed biomedical company, marking a significant strategic move to strengthen its position in the biomedical industry.
More about Enterprise Development Holdings Limited
Enterprise Development Holdings Limited operates in the investment and asset management industry, focusing on sectors such as medical research, cell technology, and biomedicine. The company aims to invest in corporations involved in these fields, enhancing its market presence in the biomedical sector.
Average Trading Volume: 27,024
Technical Sentiment Signal: Hold
Current Market Cap: HK$842.4M
See more insights into 1808 stock on TipRanks’ Stock Analysis page.